Dargaud Yesim (Y Dargaud, Yesim Dargaud)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

JMIR research protocols

Journal of thrombosis and haemostasis : JTH

European journal of haematology

Université Lyon 1 Faculte de Médecine Lyon-Est

Université Claude Bernard Lyon 1 (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Lyon 1 Faculte de Médecine Lyon-Est

France

Professor :: Hematology - Haemostasis&Thrombosis

Université Lyon 1 Faculte de Médecine Lyon-Est

France

Associate Professor Haemostasis&Thrombosis

Université Lyon 1 Faculte de Médecine Lyon-Est

France

Assistant Professor - Hemostasis&Thrombosis

Hospices Civils de Lyon

France

Resident

Education History

Université Claude Bernard Lyon 1

France

PHD

Publications

Alexandre Leuci, Mélanie Robert, Laurie Josset, Muriel Marano, Philippe Connes, Stéphanie Désage, Sandrine Meunier, Anne Lienhart, Dargaud Yesim
Stromal cell-derived factor 1 alpha (SDF-1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy. International journal of rheumatic diseases 27 (2) (2024)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Marc Trossaert, Valerie Chamouard, Christine Biron-Andréani, Alessandro Casini, Philippe De Mazancourt, Emmanuelle De Raucourt, Nicolas Drillaud, Birgit Frotscher, Philippe Gautier, Aurelien Lebreton, Valerie Roussel-Robert, Lucia Rugeri, Dargaud Yesim
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders. European journal of haematology (2023)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Dargaud Yesim, Andreas Greinacher, Pierre Fenaux, Cedric Hermans
Specialist training in thrombosis and haemostasis across Europe: From aspirations to actions. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Marc Trossaert, Chamouard Valerie, Christine Biron-Andreani, Alessandro Casini, Philippe De Mazancourt, Emmanuelle De Raucourt, Drillaud Nicolas, Frotscher Birgit, Philippe Gautier, Aurelien Lebreton, Roussel-Robert Valerie, Lucia Rugeri, Dargaud Yesim
Management of rare inherited bleeding disorders: proposals of the French Reference Centre on Haemophilia and rare coagulation disorders. European journal of haematology (2023)
Stéphanie Désage, Alexandre Leuci, Nathalie Enjolras, Lori A Holle, Sneha Singh, Xavier Delavenne, Alisa S Wolberg, Arijit Biswas, Dargaud Yesim
Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Geneviève Pietu, Nicolas Giraud, Valérie Chamouard, Gaétan Duport, Anne Lienhart, Dargaud Yesim
Perspectives and perception of haemophilia gene therapy by French patients. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Claude Négrier, Johannes Oldenburg, Gili Kenet, Shannon L Meeks, Jean-Claude Bordet, Jens Müller, Sandra Le Quellec, Peter L Turecek, Nikola Tripkovic, Dargaud Yesim
Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors. Research and practice in thrombosis and haemostasis 6 (4) (2022)
Dargaud Yesim, Maissa Janbain
Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence. Journal of blood medicine 12 (2021)
Dargaud Yesim, Carmen Escuriola-Ettingshausen
Recombinant porcine factor VIII: Lessons from the past and place in the management of hemophilia A with inhibitors in 2021. Research and practice in thrombosis and haemostasis 5 (8) (2021)
Remi Benoit, Christophe Nougier, Helene Desmurs-Clavel, Marie Simon, Dargaud Yesim
The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapy. International journal of laboratory hematology (2021)
Maissa Janbain, Nathalie Enjolras, Radu Bolbos, Marie Brevet, Jean-Claude Bordet, Dargaud Yesim
Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Xavier Delavenne, Edouard Ollier, Anne Lienhart, Dargaud Yesim
A new paradigm for personalized prophylaxis for patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 26 (2) (2020)
Lorine Giffard-Quillon, Helene Desmurs-Clavel, Claire Grange, Yohann Jourdy, Dargaud Yesim
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation? Thrombosis journal 18 (2020)
Christophe Nougier, Remi Benoit, Dargaud Yesim
Response to "Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation": Don't throw the baby out with the bathwater. Journal of thrombosis and haemostasis : JTH 18 (11) (2020)
Christophe Nougier, Remi Benoit, Marie Simon, Helene Desmurs-Clavel, Guillaume Marcotte, Laurent Argaud, Jean Stephane David, Aurelie Bonnet, Claude Negrier, Dargaud Yesim
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. Journal of thrombosis and haemostasis : JTH 18 (9) (2020)
Maissa Janbain, Nathalie Enjolras, Jean-Claude Bordet, Radu Bolbos, Marie Brevet, Cindy Leissinger, Dargaud Yesim
Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study. Journal of thrombosis and haemostasis : JTH 18 (3) (2019)
Dargaud Yesim, Xavier Delavenne, D P Hart, S Meunier, P Mismetti
Individualized PK-based prophylaxis in severe haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia (2018)
S Le Quellec, A Desjonqueres, L Rugeri, H Desmurs Clavel, F Farhat, L Mechtouff, Dargaud Yesim
Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency. Thrombosis journal 16 (2018)
Dargaud Yesim, C Negrier, L Rusen, Jerzy Windyga, P Georgiev, J Bichler, C Solomon, S Knaub, T Lissitchkov, R Klamroth
Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in previously treated patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 24 (4) (2018)

Dargaud Yesim.css-eqlu8i{font-size:small;padding-left:4px;} (Y Dargaud, Yesim Dargaud)

Publication Activity (10 Years)

Top Topics

Top Venues

Dargaud Yesim (Y Dargaud, Yesim Dargaud)